Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: The MIB-1 labeling index is the most effective parameter

Journal of Gastroenterology

Volumn 33, Issue 2, 1998, Pages 229-235

  Saito, Yoshifumi ^a   Matsuzaki, Yasushi ^b   Doi, Mikio ^a   Sugitani, Takehiko ^a   Chiba, Toshiya ^b   Abei, Masato ^b   Shoda, Junichi ^b   Tanaka, Naomi ^b  

^a Tsukuba Medical Center   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

HCC; Tumor volume doubling time mIB 1 monoclonal antibody

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER GROWTH; CELL NUCLEUS; CLINICAL ARTICLE; CYTOPLASM; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LABELING INDEX; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; AUTOANTIGENS; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS; CYTOPLASM; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031914261     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050075     Document Type: Article

References (24)

1. Majima Y. Growth rate of hepatocellular carcinoma by ultrasonography and its clinical significance (in Japanese with English abstract). Acta Hepatol Jap 1984;25:754-765.
2. Okazaki N, Yoshino M, Yoshida T, et al. Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. Cancer 1989;63:2207-2210.
3. Koshibu Y, Ohto M, Ebara M, et al. Growth and extension of small hepatocellular carcinoma during natural course (in Japanese with English abstract). Acta Hepatol Jap 1986;83:800-811.
4. Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular carcinoma smaller than 3cm complicating cirrhosis. Gastroenterology 1986;90:289-298.
5. Sheu J, Sung J, Chen D, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985;89:259-266
6. Barbara L, Benzi G, Gaiani S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132-137.
7. Okada S, Okazaki N, Nose H, et al. Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time. Hepato-Gastroenterol 1993;40:311-315.
8. Terada T, Nakamura Y. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. Cancer 1992;70:591-598.
9. Kawakita N, Seki S, Sakaguchi H, et al. Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde. Am J Pathol 1992;140:513-520.
10. Tarao K, Shimizu A, Harada M, et al. In vitro uptake of bromodeoxyuridine by human hepatocellular carcinoma and its relation to histopathologic findings and biologic behavior. Cancer 1991;68:1789-1794.
11. Tarao K, Ohkawa S, Shimizu A, et al. Significance of hepatocellular carcinoma proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer 1993;73:1149-1154.
12. Seki S, Sakaguchi H, Kawakita N, et al. An analysis of proliferating cells in biopsy specimens from patients with small hepatocellular carcinoma. Cancer 1992;69:2433-2439.
13. Kimura H, Kagawa K, Deguchi T, et al. Evaluation of proliferative activity in hepatocellular carcinoma by Ki-67 immunostaining of paraffin-embedded tissues after antigen retrieval. Intern Hepatol Comm 1994;2:99-104.
14. Watanabe S. Assessment of the proliferates activity of hepatocellular carcinoma with the monoclonal antibody Ki-67 using flow cytometry (in Japanese with English abstract). J Jpn Surg Soc 1995;96:439-447.
15. Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-12.
16. Cattoretti G, Backer MHG, Key G. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-363.
17. Edmondson H, Steiner P. Primary carcinoma of the liver: A study of 100 cases among 48900 necropsies. Cancer 1954:462-503.
18. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-993.
19. Schwartz M. A biomathematical approach to clinical tumor growth. Cancer 1964;14:1272-1294.
20. Grigioni W, D'errico A, Bacci F, et al. Primary liver neoplasms: Evaluation of proliferative index using MoAb Ki-67. J Pathol 1989;158:23-29.
21. Giannini Z, Zampi G, Bartoloni F, et al. Morphological precursors of hepatocellular carcinoma: A morphometrical analysis. Hepato-Gastroenterol 1987;34:95-97.
22. Motohashi I, Okudaira M, Takai T. Micro-morphometric investigations of hepatocellular carcinomas (HCC) and HCC-like liver lesions with particular emphasis on nuclear and cellular pleomorphism (in Japanese with English abstract). Acta Hepatol Jpn 1990;31:1274-1281.
23. Motohashi I. A morphometrical study on hepatocellular carcinoma (HCC) and HCC-like tumors of the liver by means of image analyzer (in Japanese with English abstract). Acta Hepatol Jap 1990;31:625-635.
24. Kondo F, Wada K, Kondo Y. Morphometric analysis of hepatocellular carcinoma. Virchows Arch A Pathol Anat Histopathol 1988;413:425-450.